Thrombolytic therapy

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Following the successful application of thrombolytic therapy for acute myocardial infarction, investigations have proceeded on several different thrombolytic agents as therapy for ischemic stroke. Early clot lysis has been demonstrated following both intra-arterial and intravenous drug administration. Clinical outcomes have been encouraging, but conclusions regarding efficacy must await the completion of randomized clinical trials. Intracerebral hemorrhage following thrombolytic therapy for ischemic stroke is not uncommon and may be fatal, and risk factors for this complication have been difficult to identify.

Original languageEnglish (US)
Pages (from-to)219-232
Number of pages14
JournalNeurologic Clinics
Volume10
Issue number1
StatePublished - 1992
Externally publishedYes

Fingerprint

Thrombolytic Therapy
Stroke
Fibrinolytic Agents
Cerebral Hemorrhage
Intravenous Administration
Randomized Controlled Trials
Myocardial Infarction
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Thrombolytic therapy. / Brott, Thomas G.

In: Neurologic Clinics, Vol. 10, No. 1, 1992, p. 219-232.

Research output: Contribution to journalArticle

Brott, TG 1992, 'Thrombolytic therapy', Neurologic Clinics, vol. 10, no. 1, pp. 219-232.
Brott, Thomas G. / Thrombolytic therapy. In: Neurologic Clinics. 1992 ; Vol. 10, No. 1. pp. 219-232.
@article{286b49217e4348df89c9b7a6c2ecc509,
title = "Thrombolytic therapy",
abstract = "Following the successful application of thrombolytic therapy for acute myocardial infarction, investigations have proceeded on several different thrombolytic agents as therapy for ischemic stroke. Early clot lysis has been demonstrated following both intra-arterial and intravenous drug administration. Clinical outcomes have been encouraging, but conclusions regarding efficacy must await the completion of randomized clinical trials. Intracerebral hemorrhage following thrombolytic therapy for ischemic stroke is not uncommon and may be fatal, and risk factors for this complication have been difficult to identify.",
author = "Brott, {Thomas G}",
year = "1992",
language = "English (US)",
volume = "10",
pages = "219--232",
journal = "Neurologic Clinics",
issn = "0733-8619",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Thrombolytic therapy

AU - Brott, Thomas G

PY - 1992

Y1 - 1992

N2 - Following the successful application of thrombolytic therapy for acute myocardial infarction, investigations have proceeded on several different thrombolytic agents as therapy for ischemic stroke. Early clot lysis has been demonstrated following both intra-arterial and intravenous drug administration. Clinical outcomes have been encouraging, but conclusions regarding efficacy must await the completion of randomized clinical trials. Intracerebral hemorrhage following thrombolytic therapy for ischemic stroke is not uncommon and may be fatal, and risk factors for this complication have been difficult to identify.

AB - Following the successful application of thrombolytic therapy for acute myocardial infarction, investigations have proceeded on several different thrombolytic agents as therapy for ischemic stroke. Early clot lysis has been demonstrated following both intra-arterial and intravenous drug administration. Clinical outcomes have been encouraging, but conclusions regarding efficacy must await the completion of randomized clinical trials. Intracerebral hemorrhage following thrombolytic therapy for ischemic stroke is not uncommon and may be fatal, and risk factors for this complication have been difficult to identify.

UR - http://www.scopus.com/inward/record.url?scp=0026594766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026594766&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 219

EP - 232

JO - Neurologic Clinics

JF - Neurologic Clinics

SN - 0733-8619

IS - 1

ER -